Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Safety Study of the Hypo-fractionated (Large Doses) Radiation Therapy in Post-menopausal Women With Breast Cancers [Phase 1, Phase 2]
A completed Phase 1/2 safety study evaluating hypo-fractionated high-dose radiation therapy in post-menopausal women with breast cancer.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating everolimus in combination with trastuzumab and paclitaxel for HER2-positive locally advanced or metastatic breast c…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Phase II Trial for Large ER-Negative Breast Cancers [Phase 2]
Phase II trial update for large ER-negative breast cancers; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer. [NA]
Completed presurgical (neoadjuvant) trial of letrozole in early-stage breast cancer; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy plus bevacizumab for HER2-negative breast cancer in stage II/III; the study has been terminated with r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating neoadjuvant/adjuvant chemotherapy, vaccine, and adjuvant radiation therapy in p53-overexpressing stage III breast…
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer [Phase 2]
Phase II randomized trial assessing neoadjuvant neratinib and/or trastuzumab followed by postoperative trastuzumab in locally advanced HER2-…
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer [Phase 2]
Phase II trial of everolimus with or without trastuzumab in hormone-refractory metastatic breast cancer completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer [Phase 2]
A Phase II study evaluating eribulin mesylate in combination with trastuzumab and pertuzumab for HER2-positive breast cancer was terminated,…
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer [Phase 2]
Phase 2 trial updating surgical removal of sentinel and axillary lymph nodes after chemotherapy in women with stage II/IIIA/IIIB breast canc…
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating nab-paclitaxel and bevacizumab followed by bevacizumab and erlotinib in metastatic breast cancer; completed with re…
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel and carboplatin in women undergoing surgery for newly diagnosed, locally advanced breast cancer has comp…
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) Patients [Phase 1]
Phase 1 study evaluating LDE225 (sonidegib) in combination with docetaxel in advanced triple-negative breast cancer has completed with resul…
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors [Phase 2]
Phase 2 clinical trial evaluating preoperative hormone therapy in postmenopausal women with ER-positive, clinical stage II-III breast cancer…
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: 4D Image-Guided Partial Breast Radiation in Stage 0 and l Breast Cancer [NA]
Clinical trial update for 4D image-guided partial breast radiation in stage 0 and I breast cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells [Phase 2]
Phase 2 clinical trial evaluating denosumab for ER+/PR+ and/or HER2-negative metastatic breast cancer with bone metastases and detectable ci…
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy [Phase 3]
A Phase 3 clinical trial evaluating letrozole in breast cancer patients who have already received five years of aromatase inhibitor therapy …
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer [Phase 2]
Phase 2 trial update evaluating routine therapy plus moxifloxacin in advanced breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating biweekly eribulin mesylate for HER2-negative metastatic breast cancer has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer [Phase 3]
Phase 3 clinical trial update evaluating acupressure for treating nausea in women receiving combination chemotherapy for breast cancer.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine and liposomal doxorubicin in women with metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating high-dose letrozole therapy in postmenopausal women with advanced breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer [Phase 2]
Phase 2 trial update evaluating apatinib with paclitaxel and carboplatin as neoadjuvant therapy for locally advanced triple-negative breast …
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer [Phase 2]
Phase 2 trial evaluating capecitabine plus bendamustine in women with pretreated locally advanced or metastatic HER2-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement [Phase 3]
Phase 3 trial evaluating zoledronic acid for bone involvement in metastatic breast cancer, metastatic prostate cancer, or multiple myeloma; …